Baxter International – Key Facts for Investors

By Harris Dyer • Wednesday, October 15 10:04 • Permanent Link

Large-cap Health Care company Baxter International has moved 1.6% so far today on a volume of 250,447, compared to its average of 7,504,157. In contrast, the S&P 500 index moved 1.0%.

Baxter International trades -17.21% away from its average analyst target price of $28.0 per share. The 15 analysts following the stock have set target prices ranging from $19.0 to $47.0, and on average have given Baxter International a rating of hold.

Anyone interested in buying BAX should be aware of the facts below:

Baxter International has moved -37.9% over the last year, and the S&P 500 logged a change of 13.7%
Based on its trailing earnings per share of -0.48, Baxter International has a trailing 12 month Price to Earnings (P/E) ratio of -48.3 while the S&P 500 average is 29.3
BAX has a forward P/E ratio of 8.0 based on its forward 12 month price to earnings (EPS) of $2.88 per share
Its Price to Book (P/B) ratio is 1.63 compared to its sector average of 3.19
Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States.
Based in Deerfield, the company has 38,000 full time employees and a market cap of $11.91 Billion. Baxter International currently returns an annual dividend yield of 3.5%.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.